Dr. Giacomo Gorini is not included in the author byline. He should be listed as the seventeenth author and affiliated with Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America. The contribution of this author is as follows: Methodology.
Reference
- 1. Schifanella L, Barnett SW, Bissa M, Galli V, Doster MN, Vaccari M, et al. (2019) ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type. PLoS Pathog 15(12): e1008121. https://doi.org/10.1371/journal.ppat.1008121 pmid:31794588
Citation: Schifanella L, Barnett SW, Bissa M, Galli V, Doster MN, Vaccari M, et al. (2020) Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type. PLoS Pathog 16(4): e1008531. https://doi.org/10.1371/journal.ppat.1008531
Published: April 28, 2020
Copyright: © 2020 Schifanella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.